Free Trial

Envoy Medical (COCH) Competitors

Envoy Medical logo
$1.44 -0.02 (-1.03%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$1.46 +0.02 (+1.38%)
As of 08/1/2025 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

COCH vs. LUNG, INFU, BSGM, OBIO, LUCD, AVR, ICAD, ZJYL, FONR, and MBOT

Should you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Pulmonx (LUNG), InfuSystem (INFU), Biosig Technologies (BSGM), Orchestra BioMed (OBIO), Lucid Diagnostics (LUCD), Anteris Technologies Global (AVR), icad (ICAD), Jin Medical International (ZJYL), Fonar (FONR), and Microbot Medical (MBOT). These companies are all part of the "medical equipment" industry.

Envoy Medical vs. Its Competitors

Pulmonx (NASDAQ:LUNG) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Pulmonx has a net margin of -62.88% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulmonx-62.88% -66.36% -35.51%
Envoy Medical -10,961.26%N/A -233.08%

Pulmonx has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, meaning that its stock price is 121% more volatile than the S&P 500.

In the previous week, Pulmonx had 19 more articles in the media than Envoy Medical. MarketBeat recorded 20 mentions for Pulmonx and 1 mentions for Envoy Medical. Pulmonx's average media sentiment score of 0.10 beat Envoy Medical's score of -1.33 indicating that Pulmonx is being referred to more favorably in the media.

Company Overall Sentiment
Pulmonx Neutral
Envoy Medical Negative

Envoy Medical has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulmonx$83.79M0.77-$56.39M-$1.43-1.13
Envoy Medical$220K140.10-$20.80M-$1.38-1.05

Pulmonx currently has a consensus target price of $7.66, indicating a potential upside of 376.04%. Envoy Medical has a consensus target price of $9.25, indicating a potential upside of 540.14%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts clearly believe Envoy Medical is more favorable than Pulmonx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulmonx
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
Envoy Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

91.0% of Pulmonx shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 6.8% of Pulmonx shares are owned by insiders. Comparatively, 58.9% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Envoy Medical beats Pulmonx on 9 of the 16 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCH vs. The Competition

MetricEnvoy MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$31.14M$6.77B$5.48B$9.52B
Dividend YieldN/A1.32%4.73%4.08%
P/E Ratio-1.0120.9428.6723.80
Price / Sales140.1054.14373.5466.64
Price / CashN/A20.5035.4557.96
Price / Book-1.644.468.275.55
Net Income-$20.80M$174.54M$3.24B$259.03M
7 Day Performance-7.37%-5.27%-3.69%-4.59%
1 Month Performance-3.67%-3.94%4.33%4.46%
1 Year Performance-44.21%8.26%25.95%18.03%

Envoy Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCH
Envoy Medical
1.9376 of 5 stars
$1.45
-1.0%
$9.25
+540.1%
-37.2%$31.14M$220K-1.0134News Coverage
Positive News
Earnings Report
LUNG
Pulmonx
3.855 of 5 stars
$3.10
+0.3%
$11.53
+271.8%
-75.2%$124.80M$87.47M-2.15250Trending News
Earnings Report
Analyst Forecast
INFU
InfuSystem
2.8399 of 5 stars
$5.91
+0.2%
$12.50
+111.5%
N/A$124.21M$137.58M98.52410
BSGM
Biosig Technologies
2.1064 of 5 stars
$4.51
-1.3%
$10.00
+121.7%
+972.2%$123.12M$40K0.0050Gap Down
OBIO
Orchestra BioMed
2.4493 of 5 stars
$3.15
-7.4%
$14.00
+344.4%
-64.4%$120.69M$2.89M-1.774News Coverage
Gap Down
LUCD
Lucid Diagnostics
2.7079 of 5 stars
$1.09
-0.5%
$3.55
+227.2%
+25.0%$117.39M$4.35M-0.8170
AVR
Anteris Technologies Global
N/A$3.22
-3.9%
$16.50
+412.4%
N/A$116.11M$2.70M0.00138
ICAD
icad
0.8933 of 5 stars
$3.87
flat
N/AN/A$106.31M$19.61M-20.37140Positive News
ZJYL
Jin Medical International
N/A$0.64
-2.9%
N/A-76.3%$100.51M$23.50M0.00245News Coverage
Gap Down
FONR
Fonar
1.2392 of 5 stars
$15.88
-0.5%
N/A-15.1%$98.43M$102.88M12.70480
MBOT
Microbot Medical
1.8411 of 5 stars
$2.66
-8.4%
$9.00
+239.0%
+162.2%$96.59MN/A-4.0820News Coverage
Options Volume

Related Companies and Tools


This page (NASDAQ:COCH) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners